Search
for
Sort by
Research 691–720 of 1000+
- 5ARI and PSA: open questions
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- Editorial Comment
- Urological Oncology: Prostate Cancer
- Provenge is Talk of GU Malignancies Congress
- 황백(黃柏)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향
- Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens
- Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Dutasteride for Androgenetic Alopecia: Review Article
- No increased risk of CV events with dutasteride vs finasteride
- Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review
- Faculty Opinions recommendation of Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Sexual dysfunction in young men prescribed finasteride for androgenic alopecia: A large single center observational cohort study
- Androgenetic alopecia, hirsutism and hypertrichosis
- Androgenetic alopecia – Medical management
- [A new treatment for androgenetic alopecia : platelet-rich plasma injections].
- Dutasteride/finasteride
- Adverse events with finasteride or dutasteride: FAERS
- Current and Future Medical Treatment of Androgenetic Alopecia
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- 054 Post Finasteride Syndrome: Guess Who-Demographics from FDA Database
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Urinary symptoms in patients with androgenetic alopecia
- [Androgenetic alopecia].
- Ruolo dei neurosteroidi nella modulazione dopaminergica
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- ANDROGENINĖS ALOPECIJOS MEDIKAMENTINIO GYDYMO GALIMYBĖS